Axel Nogai

Cross-Reactivity of Myelin Basic Protein-Specific T Cells with Multiple Microbial Peptides: Experimental Autoimmune Encephalomyelitis Induction in TCR Transgenic Mice

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region

Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program

Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

Additional file 1: of Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma

P-041 Exploring MAGE-A1 as a Therapeutic Target in Advanced Multiple Myeloma: Expression Analysis and Phase 1 Clinical Trial of MAGE-A1-Directed TCR-1367 T Cells

Multiple Myeloma Research and Treatments

Protein Degradation and Inhibitors

Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia Research

Cancer Treatment and Pharmacology